|
| Status |
Public on Dec 21, 2022 |
| Title |
BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression |
| Organism |
Homo sapiens |
| Experiment type |
Methylation profiling by genome tiling array
|
| Summary |
Two cell lines were used for methylation profiling to investigate how BET protein inhibition sensitizes glioblastoma cells to temozolomide treatment by attenuating MGMT expression
|
| |
|
| Overall design |
Bisulphite converted genomic DNA from the 2 GBM cell lines were hybridized to the Illumina Infinium MethylationEPIC Beadchip
|
| |
|
| Contributor(s) |
Tancredi A, Gusyatiner O, Bady P, Buri M, Lomazzi R, Chiesi D, Messerer M, Hegi ME |
| Citation(s) |
36513631 |
| |
| Submission date |
Nov 08, 2022 |
| Last update date |
Dec 22, 2022 |
| Contact name |
Pierre Bady |
| E-mail(s) |
pierre.bady@unil.ch
|
| Phone |
0041 21 692 40 95
|
| Organization name |
CHUV / BCF / SIB
|
| Department |
Swiss Institute of Bioinformatics
|
| Lab |
Bioinformatics Core Facility
|
| Street address |
Quartier UNIL-Sorge
|
| City |
Lausanne |
| ZIP/Postal code |
1015 |
| Country |
Switzerland |
| |
|
| Platforms (1) |
|
| Samples (2) |
|
| Relations |
| BioProject |
PRJNA899453 |
